What is Ayogo?
Founded in 2008, Ayogo operates at the intersection of behavioral psychology and digital health technology. The company's flagship Glimpse Platform serves as a sophisticated engine for tailoring therapeutic content, tools, and support systems to the unique psychosocial characteristics of individual patients. By moving beyond generic patient support programs, Ayogo enables healthcare providers and life sciences organizations to foster deeper patient activation and long-term adherence. This enterprise-grade approach to digital therapeutics has positioned the firm as a vital partner in the global shift toward patient-centric care models, effectively bridging the gap between clinical treatment and real-world patient behavior.
How much funding has Ayogo raised?
Ayogo has raised a total of $10M across 2 funding rounds:
Series A
$2.5M
Series B
$7.5M
Series A (2015): $2.5M with participation from Merck Global Health Innovations, 7Wire Ventures, and Excel Venture Management
Series B (2020): $7.5M led by Baxter International Inc, 7Wire Ventures, MEDTEQ, Excel Venture Management, and Merck Global Health Innovation Fund
Key Investors in Ayogo
Merck Global Health Innovation Fund
A corporate venture arm of a global healthcare leader, focusing on investments in digital health and innovative technologies that improve patient outcomes.
7Wire Ventures
A venture capital firm specializing in early-stage and growth-stage investments within the connected health and digital health technology sectors.
Excel Venture Management
A life sciences-focused investment firm that supports companies developing transformative technologies at the intersection of healthcare and information technology.
What's next for Ayogo?
With the successful completion of its latest capital raise, Ayogo is well-positioned to scale its Glimpse Platform across broader therapeutic areas and international markets. The company's strategic roadmap focuses on deepening its integration with existing healthcare ecosystems, ensuring that its behavioral science capabilities are seamlessly embedded into the patient journey. As the digital health sector matures, Ayogo's focus on measurable clinical outcomes and data-driven patient engagement will likely serve as a key differentiator. Future growth initiatives are expected to prioritize the expansion of its proprietary behavioral analytics engine, further enhancing the precision of its personalized support interventions for complex chronic conditions.
See full Ayogo company page
